What we do Zenotech Laboratories Ltd is a pharmaceutical contract manufacturer specializing in parenteral depot formulations, oncology, ophthalmic, and injectable drugs primarily serving niche therapy areas. |
Founded in 1,989 |
Market share Strong niche presence in oncology and anesthesiology injectable generics under Sun Pharma's aegis. |
Problem solved Enables efficient contract manufacturing services for specialized injectable & oncology drugs addressing niche therapy needs. |
Top clients or who we serve Mainly serves Sun Pharmaceutical Industries Limited; operates in B2B pharmaceutical manufacturing sector. |
Key management Dr. Sachin Laxmanappa Gavandare (CEO), Mr. Poly K.V. (CFO), Mr. Abdul Gafoor Mohammad (Company Secretary). |
Our journey and innovations Founded as Sunline Technologies (1989), renamed in 2004, merged with multiple pharma entities, launched oncology and anesthesia products post-2005, expanded injectable facilities in 2019-20. |
Where we operate Primarily India with legacy and closed subsidiaries in Brazil, USA, and Nigeria. |
Top products or what we offer Contract manufacturing of parenteral depot formulations, oncology injectables, ophthalmic and anesthesia injectable products. |
Top brands - |
Raw materials needed Specialized pharma-grade chemical components for parenteral and oncology formulations. |
Raw materials supplier - |
Recurring vs cyclical contribution Revenue mainly from recurring contract manufacturing services. |
Our industry position Well-positioned niche player in injectable oncology and anesthesiology generics under Sun Pharma's holding. |
Financial highlights FY2024-25 revenue Rs. 39.0 crore, PAT Rs. 5.6 crore; steady revenue growth and positive profitability. |
Geographical revenue split Revenue mainly from Indian operations. |
Order book - |
Whats driving growth Increasing volume of sterile formulations, expansions in injectable manufacturing and synergy post mergers. |
Our future plans Maximizing resource utilization, operational efficiency improvement, and facility upgrades for sustained growth. |
Our green promise - |
Our people and values Committed to safety, ethical conduct, and fostering innovation with a stable workforce. |
Key challenges ahead Legacy legal issues and missing overseas records pose compliance challenges; operational cost controls needed. |
Interesting facts Merged with multiple pharma firms; leased renovated biotech API facility to Sun Pharma for R&D. |
Risks and strategy Mitigate operational and legacy legal risks through focused management, enhancing efficiencies and compliance. |
